Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fever in the Emergency Department Predicts Survival of Patients With Severe Sepsis and Septic Shock Admitted to the ICU.
Sundén-Cullberg J, Rylance R, Svefors J, Norrby-Teglund A, Björk J, Inghammar M. Sundén-Cullberg J, et al. Crit Care Med. 2017 Apr;45(4):591-599. doi: 10.1097/CCM.0000000000002249. Crit Care Med. 2017. PMID: 28141683
Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.
Sundén-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ. Sundén-Cullberg J, et al. Crit Care Med. 2005 Mar;33(3):564-73. doi: 10.1097/01.ccm.0000155991.88802.4d. Crit Care Med. 2005. PMID: 15753748
The role of high mobility group box-1 protein in severe sepsis.
Sunden-Cullberg J, Norrby-Teglund A, Treutiger CJ. Sunden-Cullberg J, et al. Curr Opin Infect Dis. 2006 Jun;19(3):231-6. doi: 10.1097/01.qco.0000224816.96986.67. Curr Opin Infect Dis. 2006. PMID: 16645483 Review.
Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.
Sundén-Cullberg J, Nyström T, Lee ML, Mullins GE, Tokics L, Andersson J, Norrby-Teglund A, Treutiger CJ. Sundén-Cullberg J, et al. Crit Care Med. 2007 Jun;35(6):1536-42. doi: 10.1097/01.CCM.0000266536.14736.03. Crit Care Med. 2007. PMID: 17452927
Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock.
Linder A, Åkesson P, Inghammar M, Treutiger CJ, Linnér A, Sundén-Cullberg J. Linder A, et al. Crit Care. 2012 May 21;16(3):R90. doi: 10.1186/cc11353. Crit Care. 2012. PMID: 22613179 Free PMC article.
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor.
Giamarellos-Bourboulis EJ, Norrby-Teglund A, Mylona V, Savva A, Tsangaris I, Dimopoulou I, Mouktaroudi M, Raftogiannis M, Georgitsi M, Linnér A, Adamis G, Antonopoulou A, Apostolidou E, Chrisofos M, Katsenos C, Koutelidakis I, Kotzampassi K, Koratzanis G, Koupetori M, Kritselis I, Lymberopoulou K, Mandragos K, Marioli A, Sundén-Cullberg J, Mega A, Prekates A, Routsi C, Gogos C, Treutiger CJ, Armaganidis A, Dimopoulos G. Giamarellos-Bourboulis EJ, et al. Crit Care. 2012 Aug 8;16(4):R149. doi: 10.1186/cc11463. Crit Care. 2012. PMID: 22873681 Free PMC article.
Short- and long-term mortality in severe sepsis/septic shock in a setting with low antibiotic resistance: a prospective observational study in a Swedish university hospital.
Linnér A, Sundén-Cullberg J, Johansson L, Hjelmqvist H, Norrby-Teglund A, Treutiger CJ. Linnér A, et al. Among authors: sunden cullberg j. Front Public Health. 2013 Nov 15;1:51. doi: 10.3389/fpubh.2013.00051. eCollection 2013. Front Public Health. 2013. PMID: 24350220 Free PMC article.
Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality.
Lange A, Sundén-Cullberg J, Magnuson A, Hultgren O. Lange A, et al. Among authors: sunden cullberg j. PLoS One. 2017 Jan 5;12(1):e0169176. doi: 10.1371/journal.pone.0169176. eCollection 2017. PLoS One. 2017. PMID: 28056053 Free PMC article.
Sex-based differences in ED management of critically ill patients with sepsis: a nationwide cohort study.
Sunden-Cullberg J, Nilsson A, Inghammar M. Sunden-Cullberg J, et al. Intensive Care Med. 2020 Apr;46(4):727-736. doi: 10.1007/s00134-019-05910-9. Epub 2020 Jan 23. Intensive Care Med. 2020. PMID: 31974918 Free PMC article.
Neutrophil-derived hyperresistinemia in severe acute streptococcal infections.
Johansson L, Linnér A, Sundén-Cullberg J, Haggar A, Herwald H, Loré K, Treutiger CJ, Norrby-Teglund A. Johansson L, et al. J Immunol. 2009 Sep 15;183(6):4047-54. doi: 10.4049/jimmunol.0901541. Epub 2009 Aug 28. J Immunol. 2009. PMID: 19717514
19 results
Jump to page
Feedback